早期脊柱植入物感染清创保留植入物后抗生素疗程:多中心队列研究
该多中心回顾性队列纳入499例早期术后脊柱植入物感染患者,采用调整Cox时变暴露模型分析抗生素疗程与治疗失败的关系。中位随访3.2年,23.2%患者治疗失败;清创后6周无失败者中,使用抗生素与失败无显著关联(aHR 0.71,95%CI 0.48-1.07;p=0.10),>12周疗程亦未显著降低失败风险(aHR 1.01,95%CI 0.62-1.64;p=0.99)。结论支持在充分外科源控制下缩短并个体化抗生素疗程。
要点
- 早期PSII清创保留植入物后,延长抗生素疗程未改善治疗结局。
- 清创后6周无失败者继续用抗生素与失败风险无显著关联。
- 充分外科源控制下可考虑更短、个体化的抗生素疗程。
核心结论
- 延长抗生素治疗与早期PSII清创保留植入物后的治疗失败风险降低无关。
- 结果支持对达到充分外科源控制的患者采用更短、个体化的抗生素疗程。
研究设计与样本
- 多中心回顾性队列研究,覆盖美国十家学术中心。
- 纳入2017至2021年早期PSII(融合术后≤90天)成人患者,排除清创后6周内治疗失败者,共499例。
- 抗生素疗效以时变暴露采用调整Cox比例风险模型分析,并做12周landmark及clone-censor-weighted模型比较≤12周与>12周疗程。
主要发现
- 499例中116例(23.2%)在中位随访3.2年内发生治疗失败。
- 清创后6周无失败者中,使用抗生素与治疗失败无显著关联(aHR 0.71,95%CI 0.48-1.07;p=0.10)。
- 12周landmark分析(限359例未接受无限期抑制性抗生素者)中,>12周疗程未显著降低失败风险(aHR 1.01,95%CI 0.62-1.64;p=0.99)。
- clone-censor-weight敏感性分析结果一致(aHR 0.85,95%CI 0.62-1.16;p=0.30)。
临床怎么用
- 对清创保留植入物且外科源控制充分的早期PSII患者,可考虑缩短抗生素疗程并个体化决策。
- 无需常规延长抗生素超过12周以降低治疗失败风险。
局限性
- 回顾性队列设计可能存在残余混杂。
- 仅纳入早期PSII(≤90天)且排除清创后6周内失败者,结论外推受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Postoperative spinal implant infections (PSII) are a serious complication of instrumented spinal fusion. Although debridement with implant retention is standard for early infection, the optimal duration of antimicrobial therapy remains uncertain. METHODS: We conducted a multicenter retrospective cohort study across ten U.S. academic centers, including adults with early PSII (≤90 days after fusion surgery) from 2017 to 2021. We excluded patients who experienced treatment failure within 6 weeks of debridement. The primary outcome was treatment failure. Antibiotic therapy effect was analyzed as a time-varying exposure using adjusted Cox proportional hazards models. Secondary analyses included 12-week landmark and clone-censor-weighted models to compare durations ≤12 weeks versus >12 weeks. RESULTS: 116 patients out of 499 (23.2%) experienced treatment failure during a median follow-up of 3.2 years. Among patients who remain failure-free six weeks from debridement, being on antibiotics was not associated with treatment failure (adjusted hazard ratio [aHR] 0.71, 95% confidence interval [CI] 0.48-1.07; p = 0.10). In a 12-week landmark analysis limited to 359 patients who were not on indefinite suppressive antibiotic therapy, treatment durations >12 weeks did not significantly reduce the risk of failure (aHR 1.01, 95% CI 0.62-1.64; p = 0.99). Results were consistent in the clone-censor-weight sensitivity analysis (aHR 0.85, 95% CI 0.62-1.16; p = 0.30). CONCLUSIONS: Prolonged antibiotic therapy was not associated with improved outcomes in early PSII managed with debridement and implant retention. These results support shorter, individualized antibiotic courses in patients with adequate surgical source control.
引用
- Tai DBG, Poehlein E, O'Neil JC, et al. Antibiotic Duration after Debridement and Implant Retention for Early Postoperative Spinal Implant Infections: A Multicenter Cohort Study. Clin Infect Dis. 2026. PMID: 42084484. doi:10.1093/cid/ciag300
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。